• Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy 

      Gallo, Giovanna; Mastromarino, Vittoria; Limongelli, Giuseppe; Calcagni, Giulio; Maruotti, Antonello; Ragni, Luca; Valente, Fabio; Musumeci, Beatrice; Adorisio, Rachele; Rubino, Marta; Autore, Camillo; Magrì, Damiano (Journal article; Peer reviewed, 2021)
      The usefulness of cardiopulmonary exercise test (CPET) in adult hypertrophic cardiomyopathy (HCM) patients is well-known, whereas its role in pediatric HCM patients has not yet been explored. The present study investigates ...
    • Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 

      Magrì, Damiano; Piepoli, Massimo; Gallo, Giovanna; Corrà, Ugo; Metra, Marco; Paolillo, Stefania; Filardi, Pasquale Perrone; Maruotti, Antonello; Salvioni, Elisabetta; Mapelli, Massimo; Vignati, Carlo; Senni, Michele; Limongelli, Giuseppe; Lagioia, Rocco; Scrutinio, Domenico; Emdin, Michele; Passino, Claudio; Parati, Gianfranco; Sinagra, Gianfranco; Correale, Michele; Badagliacca, Roberto; Sciomer, Susanna; Di Lenarda, Andrea; Agostoni, Piergiuseppe (Journal article; Peer reviewed, 2022)
      Aims Predicting maximal heart rate (MHR) in heart failure with reduced ejection fraction (HFrEF) still remains a major concern. In such a context, the Keteyian equation is the only one derived in a HFrEF cohort on optimized ...
    • Risk stratification in hypertrophic cardiomyopathy. Insights from genetic analysis and cardiopulmonary exercise testing 

      Magri, Damianio; Mastromarino, Vittoria; Gallo, Giovanna; Zachara, Elisabetta; Re, Federica; Piergiuseppe, Agostoni; Giordano, Dario; Rubattu, Speranza; Forte, Maurizio; Cotugno, Maria; Torrisi, Maria Rosaria; Petrucci, Simona; Germani, Aldo; Savio, Camilla; Maruotti, Antonello; Volpe, Massimo; Autore, Camillo; Piane, Maria; Musumeci, Beatrice (Journal article; Peer reviewed, 2020)
      The role of genetic testing over the clinical and functional variables, including data from the cardiopulmonary exercise test (CPET), in the hypertrophic cardiomyopathy (HCM) risk stratification remains unclear. A retrospective ...